Control of the Host Response to Histoplasma Capsulatum

  • George S. DeepeJr.


The mammalian host response to fungal pathogens is complex and varies with the different species in part as a result of differences in biochemical and genetic composition, portals of entry, and morphology. Among the fungal pathogens, Histoplasma capsulatum is one of the few that behaves both as a primary pathogen and as an opportunist, i.e., causes serious life-threatening infection in both immunocompetent and immunocompromised hosts. This fungus is found in the soil in many continents but does manifest a geographic restriction. The highly endemic areas are the midwestern and southeastern regions of the United States and large segments of Central and South America. The portal of entry for this fungus is the lungs. Infection of mammals is coincidental with the disruption of the soil. Most infections resolve spontaneously although the organism establishes a dormant state. Numerous mediators and cell populations must cooperate to effect a successful resolution of ­infection. Primary among them are T cells, macrophages, tumor necrosis factor-α and ­interferon-γ. However, these constituents constitute only a fraction of the mediators and cells that contribute to host regulation of invasion. The chapter herein will explore the elements of the immune response and how each contributes to regulation­. We also will endeavor to define intersections among cell populations and soluble mediators.


Nitric Oxide Dendritic Cell Yeast Cell Programme Death Ligand Fungal Burden 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Acha-Orbea, H., D. J. Mitchell, et al. (1988). “Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.” Cell 54(2): 263-73.PubMedGoogle Scholar
  2. Allen, H. L. and G. S. Deepe, Jr. (2005). “Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.” J Clin Invest 115(10): 2875–85.PubMedGoogle Scholar
  3. Allendoerfer, R. and G. S. Deepe, Jr. (1997). “Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice.” Infect Immun 65(7): 2564–9.PubMedGoogle Scholar
  4. Allendoerfer, R. and G. S. Deepe, Jr. (1998). “Blockade of endogenous TNF-α exacerbates ­primary and secondary pulmonary histoplasmosis by differential mechanisms.” J Immunol 160(12): 6072–82.PubMedGoogle Scholar
  5. Allendoerfer, R. and G. S. Deepe, Jr. (2000). “Regulation of infection with Histoplasma capsulatum by TNFR1 and -2.” J Immunol 165(5): 2657–64.PubMedGoogle Scholar
  6. Allendoerfer, R., G. P. Biovin, et al. (1997). “Modulation of immune responses in murine pulmonary histoplasmosis.” J. Infect. Dis. 175(4): 905–14.PubMedGoogle Scholar
  7. Allendorfer, R., G. D. Brunner, et al. (1999). “Complex requirements for nascent and memory immunity in pulmonary histoplasmosis.” J Immunol 162(12): 7389–96.PubMedGoogle Scholar
  8. Artz, R. P. and W. E. Bullock (1979). “Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells.” Infect Immun 23(3): 893–902.PubMedGoogle Scholar
  9. Belkaid, Y. (2003). “The role of CD4+CD25+ regulatory T cells in Leishmania infection.” Expert Opin Biol Ther 3(6): 875–85.PubMedGoogle Scholar
  10. Belkaid, Y. and B. T. Rouse (2005). “Natural regulatory T cells in infectious disease.” Nat Immunol 6(4): 353–60.PubMedGoogle Scholar
  11. Belkaid, Y., C. A. Piccirillo, et al. (2002). “CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.” Nature 420(6915): 502–7.PubMedGoogle Scholar
  12. Bettelli, E., T. Korn, et al. (2007). “Th17: the third member of the effector T cell trilogy.” Curr Opin Immunol 19(6): 652-7.PubMedGoogle Scholar
  13. Brummer, E. and D. A. Stevens (1994). “Effect of macrophage colony-stimulating factor (M-CSF) on macrophage morphology, phagocytosis, and intracellular multiplication of Histoplasma capsulatum.” Int J Immunopharmacol 16(2): 171–6.PubMedGoogle Scholar
  14. Brummer, E., N. Kurita, et al. (1991). “Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis.” J Infect Dis 164(1): 158–62.PubMedGoogle Scholar
  15. Bullock, W. E. (1993). “Interactions between human phagocytic cells and Histoplasma capsulatum.” Arch Med Res 24(3): 219–23.PubMedGoogle Scholar
  16. Bullock, W. E. and S. D. Wright (1987). “Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages.” J Exp Med 165(1): 195–210.PubMedGoogle Scholar
  17. Busch, D. H., I. Pilip, et al. (1998). “Evolution of a complex T cell receptor repertoire during ­primary and recall bacterial infection.” J Exp Med 188(1): 61–70.PubMedGoogle Scholar
  18. Cain, J. A. and G. S. Deepe, Jr. (1998). “Evolution of the primary immune response to Histoplasma capsulatum in murine lung.” Infect Immun 66: 1473–1481.PubMedGoogle Scholar
  19. Cain, J. A. and G. S. Deepe, Jr. (2000). “Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum.” Infect Immun 68: 2069–2076.PubMedGoogle Scholar
  20. Cosma, C. L., O. Humbert, et al. (2004). “Superinfecting mycobacteria home to established tuberculous granulomas.” Nat Immunol 5(8): 828–35.PubMedGoogle Scholar
  21. Couto, M. A., L. Liu, et al. (1994). “Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin.” Infect Immun 62(6): 2375–8.PubMedGoogle Scholar
  22. Davis, J. M. and L. Ramakrishnan (2009). “The role of the granuloma in expansion and dissemination of early tuberculous infection.” Cell 136(1): 37–49.PubMedGoogle Scholar
  23. Davis, J. M., H. Clay, et al. (2002). “Real-time visualization of mycobacterium-macrophage ­interactions leading to initiation of granuloma formation in zebrafish embryos.” Immunity 17(6): 693–702.PubMedGoogle Scholar
  24. Deepe, G. S., Jr. (1994). “Role of CD8+ T cells in host resistance to systemic infection with Histoplasma capsulatum in mice.” J Immunol 152(7): 3491–500.PubMedGoogle Scholar
  25. Deepe, G. S. (2007). “Tumor necrosis factor-α antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.” J Interferon Cytokine Res 27(6): 471–80.PubMedGoogle Scholar
  26. Deepe, G. S., Jr. (2010). Histoplasma capsulatum. Principles and Practices of Infectious Diseases. B. J. Mandell GL, Dolin R. Philadelphia, Elsevier Churchill Livingstone. 2: 3305–3318.Google Scholar
  27. Deepe, G. S., Jr. and R. S. Gibbons (2002). “Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum.” Infect Immun 70(7): 3759–67.PubMedGoogle Scholar
  28. Deepe, G. S., Jr. and R. S. Gibbons (2003). “Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10.” J Immunol 171(10): 5353–62.PubMedGoogle Scholar
  29. Deepe, G. S., Jr. and R. S. Gibbons (2006). “T cells require tumor necrosis factor-α to provide protective immunity in mice infected with Histoplasma capsulatum.” J Infect Dis 193(2): 322–30.PubMedGoogle Scholar
  30. Deepe, G. S., Jr. and R. S. Gibbons (2008). “TNF-α Antagonism Generates a Population of Antigen-Specific CD4+CD25+ T Cells That Inhibit Protective Immunity in Murine Histoplasmosis.” J Immunol 180(2): 1088–97.PubMedGoogle Scholar
  31. Deepe, G. S., Jr. and R. S. Gibbons (2009). “Interleukins 17 and 23 influence the host response to Histoplasma capsulatum.” J Infect Dis 200(1): 142–51.PubMedGoogle Scholar
  32. Deepe, G. S., Jr. and M. McGuinness (2006). “Interleukin-1 and host control of pulmonary histoplasmosis.” J Infect Dis 194(6): 855–64.PubMedGoogle Scholar
  33. Deepe, G. S., Jr., R. Gibbons, et al. (1999). “Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum.” J Immunol 163(9): 4985–93.PubMedGoogle Scholar
  34. Deepe, G. S., Jr., R. S. Gibbons, et al. (2002). “Discordance between T-cell receptor expression and effector function in mice infected with Histoplasma capsulatum.” Infect Immun 70(3): 1648–52.PubMedGoogle Scholar
  35. Deepe, G. S., Jr., R. S. Gibbons, et al. (2008). “Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs.” J Leukoc Biol 84(3): 669–78.PubMedGoogle Scholar
  36. Eisenhauer, P. B. and R. I. Lehrer (1992). “Mouse neutrophils lack defensins.” Infect Immun 60(8): 3446–7.PubMedGoogle Scholar
  37. Eissenberg, L. G., P. H. Schlesinger, et al. (1988). “Phagosome-lysosome fusion in P388D1 ­macrophages infected with Histoplasma capsulatum.” J Leukoc Biol 43(6): 483–91.PubMedGoogle Scholar
  38. Eissenberg, L. G., W. E. Goldman, et al. (1993). “Histoplasma capsulatum modulates the acidification of phagolysosomes.” J Exp Med 177(6): 1605–11.PubMedGoogle Scholar
  39. Fleischmann, J., B. Wu-Hsieh, et al. (1990). “The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma.” J Infect Dis 161(1): 143–5.PubMedGoogle Scholar
  40. Franceschini, D., M. Paroli, et al. (2009). “PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.” J Clin Invest 119(3): 551–64.PubMedGoogle Scholar
  41. Gildea, L. A., R. E. Morris, et al. (2001). “Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells.” J Immunol 166(2): 1049–56.PubMedGoogle Scholar
  42. Gildea, L. A., R. Gibbons, et al. (2003). “Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum.” Infect Immun 71(7): 3787–93.PubMedGoogle Scholar
  43. Gildea, L. A., G. M. Ciraolo, et al. (2005). “Human dendritic cell activity against Histoplasma capsulatum is mediated via phagolysosomal fusion.” Infect Immun 73(10): 6803–11.PubMedGoogle Scholar
  44. Gomez, A. M., W. E. Bullock, et al. (1988). “Role of L3T4+ T cells in host defense against Histoplasma capsulatum.” Infect Immun 56(7): 1685–91.PubMedGoogle Scholar
  45. Gomez, F. J., R. Allendoerfer, et al. (1995). “Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis.” Infect Immun 63(7): 2587–95.PubMedGoogle Scholar
  46. Gomez, F. J., J. A. Cain, et al. (1998). “Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis.” J Clin Invest 102(5): 984–95.PubMedGoogle Scholar
  47. Gomez, F. J., E. O. Woodward, et al. (2001). “Vβ6+ and Vβ4+ T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum.” J Immunol 166(4): 2855–62.PubMedGoogle Scholar
  48. Gomez, F. J., R. Pilcher-Roberts, et al. (2008). “Histoplasma capsulatum cyclophilin A mediates attachment to dendritic cell VLA-5.” J Immunol 181(10): 7106–14.PubMedGoogle Scholar
  49. Guimaraes, A. J., S. Frases, et al. (2009). “Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum.“ Infect Immun 77(4): 1357–67.PubMedGoogle Scholar
  50. Guimaraes, A. J., S. Frases, et al. (2010). “Agglutination of Histoplasma capsulatum by IgG monoclonal antibodies against Hsp60 impacts macrophage effector functions.” Infect Immun.79(2): 918–27PubMedGoogle Scholar
  51. Hamada, S., M. Umemura, et al. (2008). “IL-17A produced by γΔ T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver.” J Immunol 181(5): 3456–63.PubMedGoogle Scholar
  52. Heninger, E., L. H. Hogan, et al. (2006). “Characterization of the Histoplasma capsulatum-induced granuloma.” J Immunol 177(5): 3303–13.PubMedGoogle Scholar
  53. Hirsch, C. S., Z. Toossi, et al. (1999). “Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis.” J Infect Dis 179(4): 945–53.PubMedGoogle Scholar
  54. Hotchkiss, R. S., K. W. Tinsley, et al. (2001). “Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.” J Immunol 166(11): 6952–63.PubMedGoogle Scholar
  55. Hwang, L., D. Hocking-Murray, et al. (2003). “Identifying phase-specific genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray.” Mol Biol Cell 14(6): 2314–26.PubMedGoogle Scholar
  56. Inglis, D. O., C. A. Berkes, et al. (2010). “Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages.” Infect Immun 78(9): 3871–82.PubMedGoogle Scholar
  57. Ishikawa, H., Y. Li, et al. (1993). “Cytotoxic and interferon γ -producing activities of gamma delta T cells in the mouse intestinal epithelium are strain dependent.” Proc Natl Acad Sci USA 90(17): 8204–8.PubMedGoogle Scholar
  58. Keir, M. E., L. M. Francisco, et al. (2007). “PD-1 and its ligands in T-cell immunity.” Curr Opin Immunol 19(3): 309–14.PubMedGoogle Scholar
  59. Kim, S., K. B. Elkon, et al. (2004). “Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.” Immunity 21(5): 643–53.PubMedGoogle Scholar
  60. Kimura, A., T. Naka, et al. (2007). “IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.” Proc Natl Acad Sci USA 104(29): 12099–104.PubMedGoogle Scholar
  61. Kindler, V., A. P. Sappino, et al. (1989). “The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.” Cell 56(5): 731–40.PubMedGoogle Scholar
  62. Kroetz, D. N. and G. S. Deepe, Jr. (2010). “CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection.” J Immunol 184(9): 5224–31.PubMedGoogle Scholar
  63. Kurita, N., E. Brummer, et al. (1991). “Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum.” J Med Vet Mycol 29(3): 133–43.PubMedGoogle Scholar
  64. Lane, T. E., B. A. Wu-Hsieh, et al. (1993). “Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state.” Infect Immun 61(4): 1468–73.PubMedGoogle Scholar
  65. Lane, T. E., B. A. Wu-Hsieh, et al. (1994). “Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates.” Infect Immun 62(5): 1940–5.PubMedGoogle Scholar
  66. Lazar-Molnar, E., A. Gacser, et al. (2008). “The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum.” Proc Natl Acad Sci USA 105(7): 2658–63.PubMedGoogle Scholar
  67. Lin, J. S. and B. A. Wu-Hsieh (2004). “Functional T cells in primary immune response to histoplasmosis.” Int Immunol 16(11): 1663–73.PubMedGoogle Scholar
  68. Lin, J. S., C. W. Yang, et al. (2005). “Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum.” J Immunol 174(10): 6282–91.PubMedGoogle Scholar
  69. Lin, J. S., J. H. Huang, et al. (2010). “Distinct roles of complement receptor 3, Dectin-1, and sialic acids in murine macrophage interaction with Histoplasma yeast.” J Leukoc Biol 88(1): 95–106.PubMedGoogle Scholar
  70. Long, K. H., F. J. Gomez, et al. (2003). “Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages.” J Immunol 170(1): 487–94.PubMedGoogle Scholar
  71. Lopes, L. C., A. J. Guimaraes, et al. (2010). “A Histoplasma capsulatum-specific IgG1 isotype monoclonal antibody, H1C, to a 70-kilodalton cell surface protein is not protective in murine histoplasmosis.” Clin Vaccine Immunol 17(7): 1155–8.PubMedGoogle Scholar
  72. Luther, S. A. and J. G. Cyster (2001). “Chemokines as regulators of T cell differentiation.” Nat Immunol 2(2): 102–7.PubMedGoogle Scholar
  73. Marion, C. L., C. A. Rappleye, et al. (2006). “An α-(1,4)-amylase is essential for α-(1,3)-glucan production and virulence in Histoplasma capsulatum.” Mol Microbiol 62(4): 970–83.PubMedGoogle Scholar
  74. Mayfield, J. A., M. F. Fontana, et al. (2010). “Genetic control of immune cell types in fungal disease.” Proc Natl Acad Sci USA.107(51): 22202–6PubMedGoogle Scholar
  75. Medeiros, A. I., C. L. Silva, et al. (1999). “Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the β-glucan present in their cell wall.” Br J Pharmacol 128(7): 1529–37.PubMedGoogle Scholar
  76. Medeiros, A. I., A. Sa-Nunes, et al. (2008). “Leukotrienes are potent adjuvant during fungal infection: effects on memory T cells.” J Immunol 181(12): 8544–51.PubMedGoogle Scholar
  77. Mellado, M., J. M. Rodriguez-Frade, et al. (2001). “Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.” Annu Rev Immunol 19: 397–421.PubMedGoogle Scholar
  78. Mendez, S., S. K. Reckling, et al. (2004). “Role for CD4+ CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity.” J Exp Med 200(2): 201–10.PubMedGoogle Scholar
  79. Mills, K. H. (2004). “Regulatory T cells: friend or foe in immunity to infection?” Nat Rev Immunol 4(11): 841–55.PubMedGoogle Scholar
  80. Newman, S. L. and L. Gootee (1992). “Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts.” Infect Immun 60(11): 4593–7.PubMedGoogle Scholar
  81. Newman, S. L., C. Bucher, et al. (1990). “Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion.” J Clin Invest 85(1): 223–30.PubMedGoogle Scholar
  82. Newman, S. L., L. Gootee, et al. (1991). “Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.” Infect Immun 59(2): 737–41.PubMedGoogle Scholar
  83. Newman, S. L., L. Gootee, et al. (1993). “Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules.” J Clin Invest 92(2): 624–31.PubMedGoogle Scholar
  84. Newman, S. L., L. Gootee, et al. (1994). “Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.” J Clin Invest 93(4): 1422–9.PubMedGoogle Scholar
  85. Newman, S. L., L. Gootee, et al. (2000). “Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum.” Infect Immun 68(10): 5668–72.PubMedGoogle Scholar
  86. Newman, S. L., W. Lemen, et al. (2010). “Dendritic cells restrict the transformation of Histoplasma capsulatum conidia into yeasts.” Med Mycol.49(4): 356–64PubMedGoogle Scholar
  87. Nickerson, D. A., R. A. Havens, et al. (1981). “Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations.” Cell Immunol 60(2): 287–97.PubMedGoogle Scholar
  88. Nosanchuk, J. D., J. N. Steenbergen, et al. (2003). “Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum.” J Clin Invest 112(8): 1164–75.PubMedGoogle Scholar
  89. Oppermann, M. (2004). “Chemokine receptor CCR5: insights into structure, function, and regulation.” Cell Signal 16(11): 1201–10.PubMedGoogle Scholar
  90. Peng, J. K., J. S. Lin, et al. (2005). “The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection.” Int Immunol 17(2): 193–205.PubMedGoogle Scholar
  91. Rappleye, C. A., L. G. Eissenberg, et al. (2007). “Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor.” Proc Natl Acad Sci USA 104(4): 1366–70.PubMedGoogle Scholar
  92. Rossi, D. and A. Zlotnik (2000). “The biology of chemokines and their receptors.” Annu Rev Immunol 18: 217–42.PubMedGoogle Scholar
  93. Rot, A. and U. H. von Andrian (2004). “Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.” Annu Rev Immunol 22: 891–928.PubMedGoogle Scholar
  94. Ruberti, G., A. Gaur, et al. (1991). “The T cell receptor repertoire influences V beta element usage in response to myoglobin.” J Exp Med 174(1): 83–92.PubMedGoogle Scholar
  95. Saliu, O. Y., C. Sofer, et al. (2006). “Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity.” J Infect Dis 194(4): 486–92.PubMedGoogle Scholar
  96. Sallusto, F., C. R. Mackay, et al. (2000). “The role of chemokine receptors in primary, effector, and memory immune responses.” Annu Rev Immunol 18: 593–620.PubMedGoogle Scholar
  97. Sa-Nunes, A., A. I. Medeiros, et al. (2006). “Gr-1+ cells play an essential role in an experimental model of disseminated histoplasmosis.” Microbes Infect.9(12–13): 1393–401PubMedGoogle Scholar
  98. Saslaw, S. and J. Schaefer (1956). “Survival of Histoplasma capsulatum in experimental histoplasmosis in mice.” Proc Soc Exp Biol Med 91(3): 412–4.PubMedGoogle Scholar
  99. Scheckelhoff, M. and G. S. Deepe, Jr. (2002). “The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of Vβ8.1/8.2+ T cells.” J Immunol 169(10): 5818–26.PubMedGoogle Scholar
  100. Serbina, N. V., T. Jia, et al. (2008). “Monocyte-mediated defense against microbial pathogens.” Annu Rev Immunol 26: 421–52.PubMedGoogle Scholar
  101. Shafiani, S., G. Tucker-Heard, et al. (2010). “Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis.” J Exp Med 207(7): 1409–20.PubMedGoogle Scholar
  102. Smith, J. G., D. M. Magee, et al. (1990). “Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum.” J Infect Dis 162(6): 1349–53.PubMedGoogle Scholar
  103. Stobo, J. D., S. Paul, et al. (1976). “Suppressor thymus-derived lymphocytes in fungal infection.” J Clin Invest 57(2): 319–28.PubMedGoogle Scholar
  104. Strasser, J. E., S. L. Newman, et al. (1999). “Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum.” J Immunol 162(10): 6148–54.PubMedGoogle Scholar
  105. Szymczak, W. A. and G. S. Deepe, Jr. (2009). “The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity.” J Immunol 183(3): 1964–74.PubMedGoogle Scholar
  106. Szymczak, W. A. and G. S. Deepe, Jr. (2010). “Antigen-presenting dendritic cells rescue CD4-depleted CCR2−/− mice from lethal Histoplasma capsulatum infection.” Infect Immun 78(5): 2125–37.PubMedGoogle Scholar
  107. Thompson, C. B. (1995). “Apoptosis in the pathogenesis and treatment of disease.” Science 267(5203): 1456–62.PubMedGoogle Scholar
  108. Vinh, D. C., S. Y. Patel, et al. (2009). “Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.” Blood.115(8): 1519–29.PubMedGoogle Scholar
  109. Wallis, R. S., M. S. Broder, et al. (2004). “Granulomatous infectious diseases associated with tumor necrosis factor antagonists.” Clin Infect Dis 38(9): 1261–5.PubMedGoogle Scholar
  110. Watson, S. R. and W. E. Bullock (1982). “Immunoregulation in disseminated histoplasmosis: characterization of the surface phenotype of splenic suppressor T lymphocytes.” Infect Immun 37(3): 940–5.PubMedGoogle Scholar
  111. Weaver, C. T., R. D. Hatton, et al. (2007). “IL-17 family cytokines and the expanding diversity of effector T cell lineages.” Annu Rev Immunol 25: 821–52.PubMedGoogle Scholar
  112. Welsh, R. M., K. Bahl, et al. (2004). “Apoptosis and loss of virus-specific CD8+ T-cell memory.” Curr Opin Immunol 16(3): 271–6.PubMedGoogle Scholar
  113. Wheat, L. J., M. Durkin, et al. (2002). “Effect of CD40 ligand on the course of murine histoplasmosis.” Med Mycol 40(5): 501–5.PubMedGoogle Scholar
  114. Winters, M. S., Q. Chan, et al. (2010). “Metallomic analysis of macrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses.” J Infect Dis 202(7): 1136–45.PubMedGoogle Scholar
  115. Wood, K. L., C. A. Hage, et al. (2003). “Histoplasmosis after treatment with anti-tumor necrosis factor-α therapy.” Am J Respir Crit Care Med 167(9): 1279–82.PubMedGoogle Scholar
  116. Wu-Hsieh, B. (1989). “Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum.” Infect Immun 57(12): 3788–92.PubMedGoogle Scholar
  117. Wu-Hsieh, B. and D. H. Howard (1989). “Macrophage cell lines P388D1 and IC-21 stimulated with gamma interferon fail to inhibit the intracellular growth of Histoplasma capsulatum.” Infect Immun 57(9): 2903–5.PubMedGoogle Scholar
  118. Wu-Hsieh, B. A., G. S. Lee, et al. (1992). “Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice.” Infect Immun 60(10): 4230–8.PubMedGoogle Scholar
  119. Wuthrich, M., H. I. Filutowicz, et al. (2003). “Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts.” J Exp Med 197(11): 1405–16.PubMedGoogle Scholar
  120. Zamvil, S. S., D. J. Mitchell, et al. (1988). “Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis.” J Exp Med 167(5): 1586–96.PubMedGoogle Scholar
  121. Zerbe, C. S. and S. M. Holland (2005). “Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency.” Clin Infect Dis 41(4): e38–41.PubMedGoogle Scholar
  122. Zhou, P. and R. A. Seder (1998). “CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma ­capsulatum.” J Exp Med 187(8): 1315–24.PubMedGoogle Scholar
  123. Zhou, P., M. C. Sieve, et al. (1995). “IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ.” J Immunol 155(2): 785–95.PubMedGoogle Scholar
  124. Zhou, P., M. C. Sieve, et al. (1997). “Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.” Infect Immun 65(3): 936–42.PubMedGoogle Scholar
  125. Zhou, P., G. Miller, et al. (1998). “Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ.” J Immunol 160(3): 1359–68.PubMedGoogle Scholar
  126. Zhou, P., B. L. Freidag, et al. (2001). “Perforin is required for primary immunity to Histoplasma capsulatum.” J Immunol 166(3): 1968–74.PubMedGoogle Scholar
  127. Zhou, L., Ivanov, II, et al. (2007). “IL-6 programs Th-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.” Nat Immunol 8(9): 967–74.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2012

Authors and Affiliations

  1. 1.Veterans Affairs HospitalCincinnatiUSA
  2. 2.Division of Infectious DiseasesUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations